Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998
- 20 May 1999
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (20) , 1525-1532
- https://doi.org/10.1056/nejm199905203402001
Abstract
Increasing resistance to quinolones among campylobacter isolates from humans has been reported in Europe and Asia, but not in the United States. We evaluated resistance to quinolones among campylobacter isolates from Minnesota residents during the period from 1992 through 1998. All 4953 campylobacter isolates from humans received by the Minnesota Department of Health were tested for resistance to nalidixic acid. Resistant isolates and selected sensitive isolates were tested for resistance to ciprofloxacin. We conducted a case-comparison study of patients with ciprofloxacin-resistant Campylobacter jejuni isolated during 1996 and 1997. Domestic chicken was evaluated as a potential source of quinolone-resistant campylobacter. The proportion of quinolone-resistant C. jejuni isolates from humans increased from 1.3 percent in 1992 to 10.2 percent in 1998 (PC. jejuni was associated with foreign travel and with the use of a quinolone before the collection of stool specimens. However, quinolone use could account for no more than 15 percent of the cases from 1996 through 1998. The number of quinolone-resistant infections that were acquired domestically also increased during the period from 1996 through 1998. Ciprofloxacin-resistant C. jejuni was isolated from 14 percent of 91 domestic chicken products obtained from retail markets in 1997. Molecular subtyping showed an association between resistant C. jejuni strains from chicken products and domestically acquired infections in Minnesota residents. The increase in quinolone-resistant C. jejuni infections in Minnesota is largely due to infections acquired during foreign travel. However, the number of quinolone-resistant infections acquired domestically has also increased, largely because of the acquisition of resistant strains from poultry. The use of fluoroquinolones in poultry, which began in the United States in 1995, has created a reservoir of resistant C. jejuni.Keywords
This publication has 25 references indexed in Scilit:
- Antimicrobial Susceptibilities of Campylobacter jejuni and coli by Using E-Test in TaiwanScandinavian Journal of Infectious Diseases, 1998
- Ciprofloxacin- and Azithromycin-Resistant Campylobacter Causing Traveler's Diarrhea in U.S. Troops Deployed to Thailand in 1994Clinical Infectious Diseases, 1996
- Infection with ciprofloxacin-resistantCampylobacter jejuni in travellers returning from AsiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Quinolone resistance and Campylobacter spp.Journal of Antimicrobial Chemotherapy, 1995
- The induction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatmentLetters in Applied Microbiology, 1994
- Antibiotics in veterinary medicine and public healthThe Lancet, 1993
- Emergence of resistance to erythromycin and fluoroquinolones in thermotolerantCampylobacter strains isolated from feces 1987–1991European Journal of Clinical Microbiology & Infectious Diseases, 1992
- Emerging quinolone resistance in campylobactersThe Lancet, 1992
- Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicineJournal of Antimicrobial Chemotherapy, 1991
- Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adultsArchives of internal medicine (1960), 1990